Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase NA 1

Status

Recruiting 229Active not recruiting 134Completed 39Not yet recruiting 37Terminated 8Enrolling by invitation 6Suspended 5Withdrawn 4Available 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 12Genitourinary 9CNS 9Breast 6Other hematologic neoplasm 5Lymphoid 5Tumor-Agnostic 4Thoracic 4Other solid neoplasm 4Myeloid 4Sarcoma 3Dermatologic 3Plasma cell 2Gynecologic 2Head & Neck 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myeloproliferative Disorders 1Lymphoma, T-Cell 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoblastic Lymphadenopathy 1Enteropathy-Associated T-Cell Lymphoma 1COVID-19 1

Interventions

Cyclophosphamide 3Vincristine 2Specimen Handling 2Prednisone 2Doxorubicin 2zanubrutinib 1prednylidene 1fludarabine 1duvelisib 1deltacortene 1Stem Cell Transplantation 1Rituximab 1Magnetic Resonance Spectroscopy 1Leukapheresis 1Etoposide 1Cetuximab 1CVnCoV COVID-19 vaccine 1CT-P10 1COH04S1 COVID-19 vaccine 1Biopsy 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Suspended × Lymphoid × 30 days × Clear all
NCT06421155 2026-06-05

Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia

Case Comprehensive Cancer Center

Phase NA Suspended
20 enrolled
LymphoidMyeloidOther hematologic neoplasm

Myeloproliferative Disorders, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06447987 2026-06-05

Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia

City of Hope Medical Center

Phase 1 Suspended
24 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04850495 2026-06-04

Zanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma

Ohio State University Comprehensive Cancer Center

Phase 1 Suspended
38 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT04803201 2026-06-02

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

Alliance for Clinical Trials in Oncology

Phase 2 Suspended
170 enrolled
Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Enteropathy-Associated T-Cell Lymphoma

NCT05672355 2026-05-20

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

City of Hope Medical Center

Phase 2 Suspended
80 enrolled
LymphoidOther hematologic neoplasm

COVID-19, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡